Abilify and Gallbladder disorder - a phase IV clinical study of FDA data
Summary:
Gallbladder disorder is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years also take Seroquel, and have Schizophrenia.
The phase IV clinical study analyzes which people have Gallbladder disorder when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.
What is Gallbladder disorder?
Gallbladder disorder is found to be associated with 1,214 drugs and 1,778 conditions by eHealthMe. Check the latest studies of Gallbladder disorder.
97,308 people reported to have side effects when taking Abilify.
Among them, 161 people (0.17%) have Gallbladder disorder.
Among these 161 people:
How long have people been on Abilify when they have Gallbladder disorder? *
What is the gender of people who have Gallbladder disorder when taking Abilify? *
What is the age of people who have Gallbladder disorder when taking Abilify? *
What are other drugs people take besides Abilify? *
What are other side effects people have besides Gallbladder disorder? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Gallbladder disorder?
- Check whether Gallbladder disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,450 reports)
Gallbladder disorder treatments and more:
- Gallbladder disorder (27,083 reports)
How severe was Gallbladder disorder and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Gallbladder disorder:
- Gallbladder disorder (1,214 drugs)
Browse all the conditions that are associated with Gallbladder disorder:
- Gallbladder disorder (1,778 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dalfampridine cause Balance Disorder? - 9 seconds ago
- Could Cymbalta cause Dysphoria? - 14 seconds ago
- Gabapentin and Nephrotic Syndrome for Men aged 50-59 - 15 seconds ago
- Gabapentin and Nephrosis for Men aged 50-59 - 15 seconds ago
- Fungal Infection and drugs of ingredients of linaclotide - 24 seconds ago
- Lantus Solostar and Glucophage drug interactions for women aged 50-59 - 32 seconds ago
- Could Metoprolol Tartrate cause Death? - 37 seconds ago
- Eyelid Irritation and drugs of ingredients of escitalopram oxalate - 40 seconds ago
- Drug interactions of Percocet and Ibuprofen - 42 seconds ago
- Drug interactions of Erythromycin and Depo-Medrol - 50 seconds ago